Komori
Japan Lifeline (7575) · TargetAchieved

Performance Targets for the Fiscal Year Ended March 2017

First written in FY2016. 3 of 5 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2017.

5entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q1 – FY20172016: 320162017: 22017
Same theme, other companies
Consolidated earnings forecast for a specific fiscal yearA theme 31 companies write about · 4 as a headwind · 27 as a tailwind

The whole theme swung hardest in 2019: 2 of 11 companies on the "Worse" side.

5 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 31 companies compared. The sentences above are computed from all 31.
Full recordFilings, disclosures and news, newest first
  1. FY2017AchievedAnnual report

    「Accordingly, net sales for the fiscal year were ¥37,181 million, up 21.7% from the previous fiscal year.」

    Actual results for the fiscal year exceeded the FY2017 performance targets presented in FY2016 for net sales of ¥34,699 million, operating income of ¥4,686 million, ordinary income of ¥4,832 million and net income attributable to owners of the parent of ¥3,102 million.
  2. FY2017-Q3AdvancedAnnual report

    「Accordingly, net sales for the cumulative third quarter were ¥27,264 million, up 25.6% from the same period of the previous year.」

    Although the full-year performance targets were not revised, cumulative third-quarter net sales rose 25.6% from the same period of the previous year, indicating progress toward the full-year targets.
  3. FY2017-Q2AdvancedAnnual report

    「Accordingly, net sales for the cumulative second quarter were ¥17,871 million, up 28.0% year on year.」

    Although the full-year performance targets were not revised, cumulative second-quarter net sales rose 28.0% year on year, indicating progress toward the targets.
  4. FY2017-Q1AdvancedAnnual report

    「As a result, sales for the three months ended 30 June were ¥8,905 million, up 32.0% year on year.」

    Although the full-year performance targets were not revised, actual first-quarter net sales were up 32.0% year on year.
  5. FY2016First statedAnnual report

    「Accordingly, for the fiscal year ending March 2017, the company forecasts consolidated net sales of ¥34,699 million, operating income of ¥4,686 million, ordinary income of ¥4,832 million, and net income attributable to owners of the parent of ¥3,102 million, representing increases of 13.6%, 26.7%, 35.2% and 10.6%, respectively, from the previous fiscal year.」

    The company presented its forecasts for net sales, operating income, ordinary income and net income attributable to owners of the parent for the following fiscal year.
Moved together

"Absorbing Declines in Product Prices and Achieving Stable Growth" moved the same way as this thread, in the same document, in 4 of its 5 moves.

444432★123456
  1. ★This thread
  2. 1Absorbing Declines in Product Prices and Achieving Stable Growth4×
  3. 2Expansion of Unique, High-Value-Added Proprietary Products4×
  4. 3Continued Cuts to Reimbursement Prices4×
  5. 4Increase in the Sales Mix of High-Margin Proprietary Products4×
  6. 5Medical Device Business Covering Both Trading and Manufacturing3×
  7. 6Introducing the latest medical devices from overseas manufacturers to Japan2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Japan Lifeline's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.